1st Quarter - Report · 2026

Filing UUID: 229ec53d-081f-437a-90d2-416b184fb400
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-14 22:48:56
Income (reported): —
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

TRUSYNERGY

Contact: MARK LENKER
Phone: +1 202-203-0490
Address: zip:19312, city:Berwyn, state:PA, street:50 Oak Lane

Client

BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA)

Life Sciences R&D

Country: GB
Effective date: 2025-09-18

Issues lobbied + lobbyists

`HCR` — Health Issues

Rare Disease Policy and FDA Policy.

Lobbyists: MARK LENKER

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

1st Quarter - Report · 2026

Registrant (lobbying firm)

Client

Issues lobbied + lobbyists

HCR — Health Issues

`HCR` — Health Issues